Sun Pharma & Moebius Reveal Promising MM-II Osteoarthritis Data

25 Apr 2025 CW Team

Sun Pharmaceutical Industries Limited (Sun Pharma) and Israel-based Moebius Medical have jointly announced the publication of two peer-reviewed articles in Osteoarthritis and Cartilage, the official journal of the Osteoarthritis Research Society International (OARSI). These publications present key clinical and mechanistic findings on MM-II, an innovative, non-opioid treatment designed to relieve symptoms of knee osteoarthritis (OA).

MM-II is formulated as a proprietary suspension of large, empty, multilamellar liposomes. It aims to reduce joint friction and wear, ultimately alleviating pain and preserving joint health. The two new publications detail the product's significant pain relief results and unique cartilage-protective mechanism.

Key Publication Highlights:

Clinical Efficacy: The first study shares data from a Phase 2b randomised, double-blind, placebo-controlled clinical trial (NCT04506463), involving 397 participants across the US, Europe, and Asia. A single MM-II injection delivered sustained and meaningful pain relief for up to 26 weeks, with a favourable safety and tolerability profile. Read more

Mechanism of Action: The second article, titled “Empty large liposomes reduce cartilage degeneration in osteoarthritic rats by forming a lubricative coating,” reveals MM-II’s action at the cartilage level. It demonstrates that MM-II forms a lubricative layer over cartilage surfaces, reducing mechanical wear and slowing cartilage degeneration—mechanisms that may contribute to its long-term analgesic effects.

Infrastructure Transport

07 Oct 2025

ADB Approves Final $299 Million Loan For Delhi–Meerut RRTS

The Delhi–Meerut Regional Rapid Transit System (RRTS) project has achieved a key milestone with the Asian Development Bank (ADB) approving a $299 million loan as the final tranche of its Multi-Tranche Financing Facility (MFF) on 30 September. This marks the completion of ADB’s four-tranche financing for the ambitious high-speed regional transport corridor.The Delhi–Meerut RRTS project, with an estimated total cost of Rs 286.3 billion (around $3.5 billion), is being implemented through a multi-layered funding framework combining international financial institutions and contributions from ..

Mizoram’s Kaladan Transport Project To Be Completed By 2027

Mizoram Chief Minister Lalduhoma announced that the Kaladan Multi-Modal Transit Transport Project (KMMTTP) — a cross-border road link connecting southern Mizoram to the Bay of Bengal via Myanmar — is expected to be completed by 2027.Speaking at Tlanglut Kut, a major festival of the Bawm tribe, and the International Bawm Cultural Meet held in Khawmawi village, Lunglei district, Lalduhoma said he had recently met with officials from the company executing the Kaladan project, who assured him that the bilateral infrastructure initiative would be completed within the next two years.He added tha..

Bhopal Metro To Launch Orange Line With Noise Control

The Bhopal Metro is gearing up to launch its priority corridor next month, marking a major milestone for the city’s urban transport network. The Orange Line stretch from AIIMS to Subhash Nagar Depot, covering eight stations, will allow trains to run at speeds of up to 80 km/h while incorporating extensive noise and vibration control technologies, in line with the Metro Rail Transit System Guidelines for Noise and Vibrations (2015), according to the Times of India.Officials from the Madhya Pradesh Metro Rail Corporation Limited (MPMRCL) said the project places strong emphasis on minimising en..